Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing 26 - 50 of 840
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

Recruiting
  • Autoimmune Hemolytic Anemia
  • +5 more
  • cytokine essays
  • +6 more
  • Milano, Italy
    Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Luspatercept Injection [Reblozyl]
  • Alessandria, Italy
  • +22 more
Jun 20, 2023

MDS, Ferroptosis Trial in Pessac (Biological sampling)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Ferroptosis
  • Biological sampling
  • Pessac, France
  • +2 more
Jun 19, 2023

Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

Not yet recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 5, 2023

    Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • +4 more
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    May 30, 2023

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023

    Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

    Not yet recruiting
    • Myeloid Malignancy
    • +4 more
    • Telehealth Serious Illness Care Program
    • Education Control
    • Rochester, New York
      University of Rochester
    May 24, 2023

    MDS Trial (Decitabine/Cedazuridine, Magrolimab)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • (no location specified)
    Apr 18, 2023

    Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

    Not yet recruiting
    • Leukemia, Acute
    • +7 more
    • (no location specified)
    Apr 10, 2023

    MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Aachen, NRW, Germany
    • +2 more
    Mar 29, 2023

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Peripheral Blood Stem Cell Transplant
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Mar 27, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Mar 31, 2023

    MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Stockholm, Sweden
      Department of Hematology, Karolinska University Hospital
    Mar 27, 2023

    Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Mar 1, 2023

    Leukemia, Lymphoma, Myeloma Trial in Miami, Chicago, San Antonio (LLS Program)

    Not yet recruiting
    • Leukemia
    • +4 more
    • LLS Program
    • Miami, Florida
    • +2 more
    Feb 16, 2023

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Rochester, Minnesota
    • +1 more
    Feb 15, 2023

    MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Tamibarotene + Azacitidine
    • Tamibarotene Matched Placebo + Azacitidine
    • Tucson, Arizona
    • +87 more
    Feb 2, 2023

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy

    Recruiting
    • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Multiple Myeloma, MDS, Diffuse Large B Cell Lymphoma Trial in Denmark (Advance consultation concerning your life and treatment

      Recruiting
      • Multiple Myeloma
      • +3 more
      • Advance consultation concerning your life and treatment (ACT )
      • Aalborg, Denmark
      • +6 more
      Jan 31, 2023